Soulbrain Holdings Co., Ltd.
KKRX:03683037,200.00
KRW
-1,000.00
(-2.62%)
ISIN
KR7036830008
Return %
Stock
S&P 500
1Y
-13.49
13.14
3Y
5.83
80.78
5Y
-17.15
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Hyun Suk Jung
- Full Time Employees
- 75
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- 34, Pangyo-ro 255beon-gil Seongnam-si GY South Korea 13486
- IPO Date
- Jan 18, 2000
- Website
- soulbrainholdings.co.kr
- Similar Companies
- Business
- Soulbrain Holdings Co., Ltd. develops, manufactures, and supplies core materials for the semiconductor, display, and secondary battery industries primarily in South Korea and internationally. The company offers chemical vapor deposition (CVD) and atomic layer deposition (ALD) materials, etchants and cleaning agents including hydrofluoric acid and buffered oxide etchants, chemical mechanical polishing (CMP) slurries, copper metalizing products; display materials such as organic materials, thin glasses, AMOLED glass scribes and cells, optical films, resin black matrixes for LCD color filters, and BOA/BCS negative organic insulators for LCD TFT; secondary battery materials including electrolytes and lead tabs; as well as LED process materials, solar cell materials, electric vehicle electronic materials, high purity phosphoric acid, biosensors, and cosmetics. Founded in 1986 and headquartered in Seongnam-si, South Korea, Soulbrain Holdings operates through subsidiaries including Soulbrain SLD Co., Ltd. for AMOLED glass scribing, probe cards, and cells; Soulbrain optos Co., Ltd. for optical films; Fect Co., Ltd. for fluorine compound etchants; Soulbrain RASA Co., Ltd. for high purity phosphoric acid; MC Solution Co., Ltd. for LCD materials; GENIC Co., Ltd. for cosmetics; Prowell Co., Ltd. for semiconductor equipment; Soulbrain MI Co., Ltd. for Li-ion battery electrolytes in the United States; overseas production entities in China, Malaysia, and Hungary; financial arms such as Soulbrain Savings Bank Co., Ltd. and NAU IB Capital Co., Ltd.; and diagnostics firms including ARK Diagnostics, Inc., PixCell Medical Technologies Ltd., and GeneChem Inc. In November 2025, Soulbrain Holdings partnered with ARCHIMED Diagnostics in a joint venture following ARCHIMED's acquisition of a 60% stake in ARK Diagnostics, Inc., where Soulbrain reinvested in a 40% stake to advance immunoassay technologies for therapeutic drug monitoring, drugs of abuse testing, immunodiagnostics, specialty diagnostics, and veterinary applications, valuing ARK at $428 million. The company maintains a diversified portfolio across chemicals, materials, bio-healthcare, and financial services with facilities in South Korea, the United States, China, Malaysia, Hungary, and Israel.